SCHEMBL15427129

SCHEMBL15427129

CCCOc1cccc2c1C(=O)c1c(OCCC)cc(N)cc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.47
TTR P02766 2/20 0.46
ELANE P08246 6/20 0.46
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
USP2 O75604 2/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
CASP7 P55210 2/20 0.40
KMT2A Q03164 2/20 0.40
CTSG P08311 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
ATM Q13315 1/20 0.40
ABCC4 O15439 1/20 0.40
LMNA P02545 1/20 0.40
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15427134 0.93 ELANE (0.54) KCNA3TTRELANECTSGMCHR1
SCHEMBL15427118 0.90 TTR (0.55) KCNA3TTRELANEKDM4EMEN1
SCHEMBL21657908 0.89 TTR (0.39) KCNA3TTRELANEKDM4EMEN1
SCHEMBL21657775 0.88 KCNA3 (0.48) KCNA3TTRELANEKDM4EMEN1
SCHEMBL15427085 0.86 KCNA3 (0.47) KCNA3TTRELANETP53MAPT
SCHEMBL30760690 0.84 KCNA3 (0.45) KCNA3TTRELANEKDM4EMEN1
SCHEMBL30760689 0.83 SLC37A4 (0.51) KCNA3TTRELANEKDM4EMEN1
SCHEMBL15427172 0.83 ALDH1A1 (0.46) KCNA3TTRELANEKDM4EMEN1
SCHEMBL28050007 0.82 KCNA3 (0.59) KCNA3TTRELANEKDM4EMEN1
SCHEMBL30760699 0.82 KCNA3 (0.46) KCNA3TTRELANEKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL KCNA3 3827/4885TTR 4284/4885ELANE 815/4885
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof PCNA, KRAS, RECQL KCNA3 3827/4885TTR 4284/4885ELANE 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.